The
ABCs of the ADINA Act: Allergen Labeling, Bipartisan Action, and Congressional
Change
Millions of people with food allergies depend on prescription and over-the-counter medications that may contain hidden common allergens. Without clear labeling, it’s often difficult to know exactly what’s in these medications—putting individuals with food allergies at risk for potentially serious reactions.
Join us for an informative webinar that explores how a bill becomes law—through the inspiring personal lens of the ADINA (Allergen Disclosure in Non-food Articles) Act. This session will guide attendees through the legislative process, highlighting the critical role that individuals and families can play in shaping public policy. This webinar will provide an overview of the ADINA Act, which calls for clear allergen labeling and transparency on medications and will explain why this step is crucial to preventing life-threatening allergic reactions.
About the Speakers
Adina, Jennifer, and Seth Togal
Adina Togal, Mom (Jennifer), Dad (Seth) and French Bulldog Coco reside near Minneapolis, Minnesota. Adina was diagnosed with Celiac Disease, Eosinophilic Esophagitis (EoE) and a dairy allergy at age eight. She and Seth both share additional food intolerances. Jennifer has a nightshade and penicillin allergy as well as EoE.
Stephanie Gadbois, Vice President of Government Affairs, Capitol 6 Advisors
Stephanie serves as Vice President of Government Affairs for Capitol 6 Advisors. She brings more than two decades of senior-level Capitol Hill experience and draws on her deep and broad-ranging policy and appropriations expertise to assist clients in navigating federal legislative and regulatory matters.
Rachael Prusi, PharmD, MSGH
Rachael Prusi, PharmD, MSGH, is a distinguished clinical pharmacist with over 15 years of professional experience. Rachael's clinical expertise spans a variety of inpatient and outpatient settings, including internal medicine, emergency medicine, cardiology, and cardiothoracic surgery at several academic medical centers. She has been a preceptor for over 200 pharmacy students and residents, serving in roles such as residency coordinator, residency program director, and former Director of Pharmacy Education at the University of Chicago Medicine.
In addition to her clinical work, Rachael is actively involved in public health initiatives after completing her Master's degree in Global Health from Northwestern University in 2018. She serves on the board of Hillside Health Care, a nonprofit organization supporting the Toledo district of Belize, and was the in-country volunteer Director of Pharmacy from 2015-2016. Rachael transitioned to managed care in 2021, taking on the role of Director of Pharmacy for the Upper Peninsula Health Plan. In 2024, she became the Director of Clinical Specialty Solutions at Prime Therapeutics, where she advises clients on medical pharmacy strategies to develop evidence-based and cost-efficient approaches to improve population health.